Cloning, expression, and antigenicity of 14 proteins from Campylobacter jejuni

Maojun Zhang1, Fanliang Meng, Fangfang Cao

  • 1National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China. zhangmaojun@icdc.cn

Insights

Researchers explored fourteen Campylobacter jejuni genes to identify potential antigens for diagnosing infections. Recombinant glutathione S-transferase-AhpC (rGST-AhpC) showed promising reactivity, suggesting its utility in serodiagnostic tests for Campylobacter jejuni.

Area of Science:

  • Microbiology and Immunology
  • Bacterial Pathogenesis
  • Recombinant Protein Expression

Background:

  • Campylobacter jejuni is a leading cause of bacterial gastroenteritis worldwide.
  • Accurate and rapid diagnostic tools are crucial for managing C. jejuni infections.
  • Identifying specific C. jejuni antigens is key for developing effective serodiagnostic assays.

Purpose of the Study:

  • To clone, express, and purify fourteen selected C. jejuni genes in Escherichia coli.
  • To evaluate the antigenicity of the resulting recombinant proteins using immune sera.
  • To identify potential C. jejuni serodiagnostic antigens.

Main Methods:

  • Cloning and expression of fourteen C. jejuni genes in E. coli BL21.
  • Purification of recombinant proteins using histidine (His) and glutathione S-transferase (GST) affinity chromatography.
  • Assessment of protein identity and antigenicity via SDS-PAGE, mass spectrometry, Western blotting, and ELISA using anti-C. jejuni sera.

Main Results:

  • Recombinant proteins were successfully expressed and purified.
  • rHis-Omp18, rHis-PEB1, and rGST-AhpC exhibited universal and specific antigenicity against the tested sera.
  • Recombinant rGST-Cj0069 and rHis-DnaK did not react with any anti-C. jejuni sera.

Conclusions:

  • Several C. jejuni recombinant proteins demonstrated antigenicity, with varying specificities.
  • Recombinant glutathione S-transferase-AhpC (rGST-AhpC) showed significant promise as a potential serodiagnostic antigen.
  • Further validation of rGST-AhpC could lead to improved diagnostic methods for C. jejuni infections.

Related Concept Videos